Furthermore, experimental silencing of the MEG3 gene led to enhanced proliferation and migration of human PASMCs, thereby demonstrating the influence of low lncRNA MEG3 expression in PAH pathogenesis [71]. This evidence concerns the gene MEG3 and pulmonary arterial hypertension.